calendar

3 catalysts · 6 patent expiry · 5 phase 1 completion · 5 phase 2 completion · 3 drug expiry · 3 phase 1 initiation · 2 constraining patent expiry europe

★ save view ↓export CSV

next 91 dayslessmore

MonWedFri

view

agenda month

show past →

sort

soonest latest type sponsor alpha

type: drug expiry×type: approval×TA: infectious-disease×clear all

type

patent expiry6
phase 1 completion5
phase 2 completion5
drug expiry3
phase 1 initiation3
constraining patent expiry europe2

phase 2 initiation2

pdufa1

phase 3 completion1

phase 1 2 completion1

therapy area

Infectious Disease3

Week of Apr 27, 2026

›Apr 28, 2026drug expiry91d agoGSK plc — cabotegravir sodium (Drug Expiry (US))cabotegravir sodium

Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

full page →cabotegravir sodium →source: globaldata

›Apr 28, 2026drug expiry91d agoViiV Healthcare UK Ltd — cabotegravir LA (Drug Expiry (US))cabotegravir LA

Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

full page →cabotegravir LA →source: globaldata

›Apr 28, 2026drug expiry91d agoViiV Healthcare UK Ltd — cabotegravir + rilpivirine LA (Drug Expiry (US))cabotegravir + rilpivirine LA

Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

full page →cabotegravir + rilpivirine LA →source: globaldata

$GSK51.35+1.20%